• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在卵巢癌中靶向 CPSF3 依赖性转录终止的治疗。

Therapeutic targeting of CPSF3-dependent transcriptional termination in ovarian cancer.

机构信息

State Key Laboratory of Systems Medicine for Cancer, Department of Obstetrics and Gynecology, Shanghai Cancer Institute, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Shanghai Key Laboratory of Gynecologic Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Sci Adv. 2023 Nov 24;9(47):eadj0123. doi: 10.1126/sciadv.adj0123. Epub 2023 Nov 22.

DOI:10.1126/sciadv.adj0123
PMID:37992178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10664987/
Abstract

Transcriptional dysregulation is a recurring pathogenic hallmark and an emerging therapeutic vulnerability in ovarian cancer. Here, we demonstrated that ovarian cancer exhibited a unique dependency on the regulatory machinery of transcriptional termination, particularly, cleavage and polyadenylation specificity factor (CPSF) complex. Genetic abrogation of multiple CPSF subunits substantially hampered neoplastic cell viability, and we presented evidence that their indispensable roles converged on the endonuclease CPSF3. Mechanistically, CPSF perturbation resulted in lengthened 3'-untranslated regions, diminished intronic polyadenylation and widespread transcriptional readthrough, and consequently suppressed oncogenic pathways. Furthermore, we reported the development of specific CPSF3 inhibitors building upon the benzoxaborole scaffold, which exerted potent antitumor activity. Notably, CPSF3 blockade effectively exacerbated genomic instability by down-regulating DNA damage repair genes and thus acted in synergy with poly(adenosine 5'-diphosphate-ribose) polymerase inhibition. These findings establish CPSF3-dependent transcriptional termination as an exploitable driving mechanism of ovarian cancer and provide a promising class of boron-containing compounds for targeting transcription-addicted human malignancies.

摘要

转录失调是卵巢癌中反复出现的致病特征和新兴治疗弱点。在这里,我们证明卵巢癌表现出对转录终止调节机制的独特依赖性,特别是切割和多聚腺苷酸化特异性因子 (CPSF) 复合物。多个 CPSF 亚基的遗传缺失严重阻碍了肿瘤细胞的活力,我们提供的证据表明,它们不可或缺的作用集中在内切核酸酶 CPSF3 上。在机制上,CPSF 扰动导致 3'-非翻译区延长、内含子多聚腺苷酸化减少和广泛的转录通读,从而抑制致癌途径。此外,我们报告了基于苯并恶硼烷支架开发的特异性 CPSF3 抑制剂,这些抑制剂具有很强的抗肿瘤活性。值得注意的是,CPSF3 阻断通过下调 DNA 损伤修复基因有效加剧基因组不稳定性,从而与聚(腺苷酸 5'-二磷酸-核糖)聚合酶抑制协同作用。这些发现确立了 CPSF3 依赖性转录终止作为卵巢癌可利用的驱动机制,并为靶向转录成瘾性人类恶性肿瘤提供了一类有前途的含硼化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/1516062b7120/sciadv.adj0123-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/99bdfe38edb1/sciadv.adj0123-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/521e861fb802/sciadv.adj0123-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/96f1e302a614/sciadv.adj0123-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/946eba68ae7c/sciadv.adj0123-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/c0dc17fbadc7/sciadv.adj0123-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/3447dc1c43d4/sciadv.adj0123-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/1516062b7120/sciadv.adj0123-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/99bdfe38edb1/sciadv.adj0123-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/521e861fb802/sciadv.adj0123-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/96f1e302a614/sciadv.adj0123-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/946eba68ae7c/sciadv.adj0123-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/c0dc17fbadc7/sciadv.adj0123-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/3447dc1c43d4/sciadv.adj0123-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e7/10664987/1516062b7120/sciadv.adj0123-f7.jpg

相似文献

1
Therapeutic targeting of CPSF3-dependent transcriptional termination in ovarian cancer.在卵巢癌中靶向 CPSF3 依赖性转录终止的治疗。
Sci Adv. 2023 Nov 24;9(47):eadj0123. doi: 10.1126/sciadv.adj0123. Epub 2023 Nov 22.
2
Anticancer benzoxaboroles block pre-mRNA processing by directly inhibiting CPSF3.抗癌苯并恶嗪通过直接抑制 CPSF3 阻断前体 mRNA 加工。
Cell Chem Biol. 2024 Jan 18;31(1):139-149.e14. doi: 10.1016/j.chembiol.2023.10.019. Epub 2023 Nov 14.
3
Cleavage and polyadenylation-specific factor 3 induces cell cycle arrest via PI3K/Akt/GSK-3β signaling pathways and predicts a negative prognosis in hepatocellular carcinoma.剪接因子 3 通过 PI3K/Akt/GSK-3β 信号通路诱导细胞周期停滞,并预测肝癌的不良预后。
Biomark Med. 2021 Apr;15(5):347-358. doi: 10.2217/bmm-2021-0039. Epub 2021 Mar 5.
4
Clinical and veterinary trypanocidal benzoxaboroles target CPSF3.临床和兽医杀锥虫苯并恶唑类化合物靶向 CPSF3。
Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):9616-9621. doi: 10.1073/pnas.1807915115. Epub 2018 Sep 5.
5
Human immunodeficiency virus type 1 Tat increases the expression of cleavage and polyadenylation specificity factor 73-kilodalton subunit modulating cellular and viral expression.1型人类免疫缺陷病毒Tat蛋白增加切割和聚腺苷酸化特异性因子73千道尔顿亚基的表达,从而调节细胞和病毒的表达。
J Virol. 2004 Jul;78(13):6846-54. doi: 10.1128/JVI.78.13.6846-6854.2004.
6
Recent molecular insights into canonical pre-mRNA 3'-end processing.近期对经典前体 mRNA 3'端加工的分子认识。
Transcription. 2020 Apr;11(2):83-96. doi: 10.1080/21541264.2020.1777047. Epub 2020 Jun 11.
7
LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.长链非编码 RNA CASC9 与 CPSF3 相互作用,调节结直肠癌中的 TGF-β 信号通路。
J Exp Clin Cancer Res. 2019 Jun 11;38(1):249. doi: 10.1186/s13046-019-1263-3.
8
CSR1 induces cell death through inactivation of CPSF3.CSR1通过使CPSF3失活诱导细胞死亡。
Oncogene. 2009 Jan 8;28(1):41-51. doi: 10.1038/onc.2008.359. Epub 2008 Sep 22.
9
CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing.CPSF3 抑制通过破坏核心组蛋白 mRNA 加工来阻止胰腺癌细胞增殖。
RNA. 2024 Feb 16;30(3):281-297. doi: 10.1261/rna.079931.123.
10
Cleavage and polyadenylation machinery as a novel targetable vulnerability for human cancer.切割与聚腺苷酸化机制作为人类癌症一种新的可靶向性弱点。
Cancer Gene Ther. 2024 Jul;31(7):957-960. doi: 10.1038/s41417-024-00770-y. Epub 2024 Apr 17.

引用本文的文献

1
Small molecule inhibition of CPSF3 impacts R-loop distribution and abundance.小分子对CPSF3的抑制作用会影响R环的分布和丰度。
bioRxiv. 2025 May 7:2025.05.07.652284. doi: 10.1101/2025.05.07.652284.
2
CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells.CPSF1抑制促进基因间聚腺苷酸化位点的广泛使用并损害前列腺癌细胞中的糖酵解。
Cell Rep. 2025 Jan 28;44(1):115211. doi: 10.1016/j.celrep.2024.115211. Epub 2025 Jan 22.
3
LINC00470 promotes malignant progression of testicular germ cell tumors.

本文引用的文献

1
Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study.阿替利珠单抗、贝伐单抗联合GEMOX三联疗法治疗晚期胆管癌的疗效和安全性:一项多中心、单臂、回顾性研究
Therap Adv Gastroenterol. 2023 Mar 28;16:17562848231160630. doi: 10.1177/17562848231160630. eCollection 2023.
2
Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer.双重抑制 CDK12/CDK13 可同时靶向卵巢癌细胞和免疫细胞。
Cancer Res. 2022 Oct 4;82(19):3588-3602. doi: 10.1158/0008-5472.CAN-22-0222.
3
Cancer statistics, 2022.
LINC00470 促进睾丸生殖细胞肿瘤的恶性进展。
Mol Biol Rep. 2024 Nov 14;51(1):1152. doi: 10.1007/s11033-024-10083-w.
4
Aberrant pre-mRNA processing in cancer.癌症中的异常前体 mRNA 处理。
J Exp Med. 2024 Nov 4;221(11). doi: 10.1084/jem.20230891. Epub 2024 Sep 24.
5
A pan-cancer analysis of the core pre-mRNA 3' end processing factors, and their association with prognosis, tumor microenvironment, and potential targets.泛癌症分析核心前体 mRNA 3' 端加工因子及其与预后、肿瘤微环境和潜在靶点的关联。
Sci Rep. 2024 Jul 29;14(1):17428. doi: 10.1038/s41598-024-57402-6.
癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
4
Targeting transcription cycles in cancer.针对癌症中的转录周期。
Nat Rev Cancer. 2022 Jan;22(1):5-24. doi: 10.1038/s41568-021-00411-8. Epub 2021 Oct 21.
5
Comprehensive characterization of somatic variants associated with intronic polyadenylation in human cancers.全面分析与人类癌症内含子多聚腺苷酸化相关的体细胞变异。
Nucleic Acids Res. 2021 Oct 11;49(18):10369-10381. doi: 10.1093/nar/gkab772.
6
A real-time fluorescence assay for CPSF73, the nuclease for pre-mRNA 3'-end processing.一种用于CPSF73(前体mRNA 3'末端加工核酸酶)的实时荧光检测方法。
RNA. 2021 Oct;27(10):1148-1154. doi: 10.1261/rna.078764.121. Epub 2021 Jul 6.
7
An atlas of alternative polyadenylation quantitative trait loci contributing to complex trait and disease heritability.一个替代性多聚腺苷酸化数量性状基因座图谱,有助于复杂性状和疾病遗传率。
Nat Genet. 2021 Jul;53(7):994-1005. doi: 10.1038/s41588-021-00864-5. Epub 2021 May 13.
8
Treatment of epithelial ovarian cancer.上皮性卵巢癌的治疗。
BMJ. 2020 Nov 9;371:m3773. doi: 10.1136/bmj.m3773.
9
CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcoma.CPSF3 依赖性的前体 mRNA 处理作为 AML 和尤文肉瘤的一个可用药节点。
Nat Chem Biol. 2020 Jan;16(1):50-59. doi: 10.1038/s41589-019-0424-1. Epub 2019 Dec 9.
10
Structural Insights into the Human Pre-mRNA 3'-End Processing Machinery.人类前体信使核糖核酸3'端加工机制的结构洞察
Mol Cell. 2020 Feb 20;77(4):800-809.e6. doi: 10.1016/j.molcel.2019.11.005. Epub 2019 Dec 3.